Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone Adjunctive Therapy for Severe Malaria in Children
NCT02694874Completed
- Sponsor
- Manhiça Health Research Centre
- Start
- Feb 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in malaria comparing Rosiglitazone with Placebo (2 arms). Primary endpoint: Change in serum Ang-2 levels at 96 hours. Started Feb 2016; status: completed.
02
Drugs
rosiglitazone
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02694874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02694874.